Skip to main content
    M

    Milestone Scientific (MLSS)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

    $0.28
    -0.01 (-3.91%)

    Market Cap: $26.64M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Milestone Scientific (MLSS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Milestone Scientific (MLSS) has a market cap of $26.64M and an enterprise value of $25.32M. Its share count is up 14.08% from a year earlier. It kept -40.27% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 4.94% below the market cap, as cash exceeds debt.

    Market Cap$26.64M
    Enterprise Value$25.32M
    Latest price (Nov 17, 2026)$0.28

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.84% in the quarter ended Sep 30, 2026 and grew 8.37% a year over 2 years.

    Shares Outstanding93.91M
    Shares Change (YoY)+14.08%
    Shares Change (QoQ)+0.84%
    Share Count Growth (2Y CAGR)+8.37%

    Valuation Ratios

    Sales and book value multiples are 2.9x and 7.3x. Its year-end P/S ranged from 1.3x to 23.1x from 2016 to 2025.

    P/S Ratio2.9x
    Forward P/S2.7x
    P/B Ratio7.3x
    P/TBV Ratio7.3x

    Valuation history and multiples

    Price Statistics

    The stock is down 14.39% over 52 weeks and trades 20.00% below its 50-day average.

    Beta (1Y)1.26
    52-Week Change-14.39%
    1-Month Change-15.17%
    3-Month Change-39.91%
    6-Month Change-18.59%
    5-Year Change-85.21%
    10-Year Change-83.54%
    Total Return (1Y)-14.39%
    Total Return (5Y CAGR)-36.11%
    Max Drawdown (1Y)-48.91%
    Max Drawdown (3Y)-81.47%
    Sharpe Ratio (1Y)-0.10
    Correlation with SPY (1Y)0.22
    50-Day Average$0.35
    200-Day Average$0.36
    52-Week Range$0.22 to $0.58
    RSI (14 Days)38.6
    Average Volume (20 Days)118.62K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.06x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.06x
    Quick Ratio0.84x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -102.21% over the last 12 months, against a 5-year average of -97.19%.

    Return on Equity (ROE)-102.21%
    Return on Assets (ROA)-53.83%
    Return on Capital Employed (ROCE)-101.43%
    ROE (5Y Average)-97.19%
    ROA (5Y Average)-56.31%
    Asset Turnover1.20x
    Inventory Turnover0.64x
    Receivables Turnover8.40x
    Cash Conversion Cycle261 days

    Scores

    MLSS has an Altman Z-Score of -22.42, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-22.42
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $9.28M over the last 12 months is up 3.93% from the 12 months before.

    Revenue$9.28M
    Revenue Growth (YoY)+3.93%
    Gross Profit$6.58M
    Operating Income-$3.72M
    Pretax Income-$3.74M
    Net Income-$3.74M
    EBITDA-$3.52M
    EBIT-$3.72M
    Reported EPS (TTM)-$0.04

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 52.74% of the $6.94M in total assets.

    Cash and Equivalents$1.32M
    Total Debt$0
    Net Cash$1.32M
    Net Cash Per Share$0.01
    Working Capital$3.49M
    Shareholder Equity$3.66M
    Book Value Per Share$0.04
    Tangible Book Value$3.63M
    Tangible Book Per Share$0.04
    Total Assets$6.94M
    Total Liabilities$3.29M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $10.55K of capital spending, operating cash flow left -$1.48M of free cash flow.

    Operating Cash Flow-$1.47M
    Capital Expenditures$10.55K
    Free Cash Flow-$1.48M
    FCF Per Share-$0.02
    Depreciation and Amortization$197.37K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -40.04%, against a 5-year average of -77.19%.

    Gross Margin70.91%
    Operating Margin-40.04%
    Pretax Margin-40.27%
    Net Margin-40.27%
    EBITDA Margin-37.91%
    EBIT Margin-40.04%
    FCF Margin-15.96%
    Gross Margin (5Y Average)66.40%
    Operating Margin (5Y Average)-77.19%
    Net Margin (5Y Average)-71.15%

    Growth

    Revenue grew 0.63% a year over 3 years.

    Revenue Growth (3Y CAGR)+0.63%
    Revenue Growth (5Y CAGR)+10.54%
    Book Value Per Share Growth (2Y CAGR)-41.09%
    Tangible Book Per Share Growth (2Y CAGR)-41.21%

    Revenue and profit by year

    Dividends and Yields

    MLSS does not pay a dividend. Its free cash flow yield is -5.58%.

    FCF Yield-5.58%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-3 reverse split on Jan 14, 2004.

    Last Split DateJan 14, 2004
    Split TypeReverse split
    Split Ratio1:3

    Peer Position

    Against 11 similar companies, MLSS has the 8th highest P/S.

    P/S Ratio2.9x vs 3.1x median
    Revenue Growth (Trailing 4 Quarters, YoY)+3.93% vs +4.84% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 12.46% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+12.46%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MLSS

    What is MLSS's market cap?

    Milestone Scientific has a market cap of $26.64M. Its enterprise value, which adds debt and subtracts cash, is $25.32M.

    How many shares of MLSS are outstanding?

    Milestone Scientific has 93.91M shares outstanding. The count is up 14.08% from a year earlier.

    Does MLSS pay a dividend?

    No. Milestone Scientific does not pay a dividend.

    How much debt does MLSS have?

    Milestone Scientific has $0 of total debt and $1.32M of cash and equivalents, a net cash position of $1.32M.